GB0124953D0 - Organic Compounds - Google Patents

Organic Compounds

Info

Publication number
GB0124953D0
GB0124953D0 GBGB0124953.1A GB0124953A GB0124953D0 GB 0124953 D0 GB0124953 D0 GB 0124953D0 GB 0124953 A GB0124953 A GB 0124953A GB 0124953 D0 GB0124953 D0 GB 0124953D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0124953.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9924043&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB0124953(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB0124953.1A priority Critical patent/GB0124953D0/en
Publication of GB0124953D0 publication Critical patent/GB0124953D0/en
Priority to ARP020103852A priority patent/AR036813A1/es
Priority to TW091123694A priority patent/TWI333861B/zh
Priority to PE2002001013A priority patent/PE20030476A1/es
Priority to CO02092380A priority patent/CO5390076A1/es
Priority to KR1020047005588A priority patent/KR100671367B1/ko
Priority to DK02777314.2T priority patent/DK1438040T4/da
Priority to HK05100153.8A priority patent/HK1067861B/en
Priority to PL415001A priority patent/PL415001A1/pl
Priority to AU2002338897A priority patent/AU2002338897B2/en
Priority to AT02777314T priority patent/ATE374023T1/de
Priority to IL16096802A priority patent/IL160968A0/xx
Priority to DE60222687.2T priority patent/DE60222687T3/de
Priority to CA002460574A priority patent/CA2460574A1/en
Priority to PCT/EP2002/011589 priority patent/WO2003032978A1/en
Priority to JP2003535782A priority patent/JP2005508959A/ja
Priority to BRPI0213355-5A priority patent/BR0213355A/pt
Priority to PT02777314T priority patent/PT1438040E/pt
Priority to EP02777314.2A priority patent/EP1438040B2/en
Priority to MYPI20023865A priority patent/MY139206A/en
Priority to MXPA04003636A priority patent/MXPA04003636A/es
Priority to SI200230646T priority patent/SI1438040T2/sl
Priority to RU2004115332/15A priority patent/RU2338528C2/ru
Priority to NZ532280A priority patent/NZ532280A/en
Priority to PL367738A priority patent/PL234541B1/pl
Priority to ES02777314T priority patent/ES2292819T5/es
Priority to US10/492,289 priority patent/US20050013859A1/en
Priority to HU0600451A priority patent/HU231114B1/hu
Priority to CNB028198611A priority patent/CN1310640C/zh
Priority to EC2002004342A priority patent/ECSP024342A/es
Priority to EC2002004341A priority patent/ECSP024341A/es
Priority to ZA200401977A priority patent/ZA200401977B/en
Priority to IL160968A priority patent/IL160968A/en
Priority to NO20041785A priority patent/NO341804B1/no
Priority to RU2007130786/15A priority patent/RU2381026C2/ru
Priority to CY20071101618T priority patent/CY1107841T1/el
Priority to JP2009012781A priority patent/JP2009137996A/ja
Priority to US12/772,608 priority patent/US20100210717A1/en
Priority to ARP120101574A priority patent/AR085778A2/es
Priority to US13/482,003 priority patent/US20120237601A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0124953.1A 2001-10-17 2001-10-17 Organic Compounds Ceased GB0124953D0 (en)

Priority Applications (40)

Application Number Priority Date Filing Date Title
GBGB0124953.1A GB0124953D0 (en) 2001-10-17 2001-10-17 Organic Compounds
ARP020103852A AR036813A1 (es) 2001-10-17 2002-10-15 Composiciones farmaceuticas
TW091123694A TWI333861B (en) 2001-10-17 2002-10-15 Enteric coated solid dosage form of mycophenolic acid or its salt, and process for preparing the same
PE2002001013A PE20030476A1 (es) 2001-10-17 2002-10-15 Composiciones farmaceuticas de acido micofenolico
CO02092380A CO5390076A1 (es) 2001-10-17 2002-10-15 Composiciones farmaceuticas
HU0600451A HU231114B1 (hu) 2001-10-17 2002-10-16 Mikofenolsavat vagy mikofenolátot tartalmazó gyógyszerkészítmények
CNB028198611A CN1310640C (zh) 2001-10-17 2002-10-16 药物组合物
MYPI20023865A MY139206A (en) 2001-10-17 2002-10-16 Pharmaceuticals compositions comprising mycophenolic acid or mycophenolate salt
RU2004115332/15A RU2338528C2 (ru) 2001-10-17 2002-10-16 Фармацевтические композиции, содержащие микофенольную кислоту или соль (микофенолят)
HK05100153.8A HK1067861B (en) 2001-10-17 2002-10-16 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt
PL415001A PL415001A1 (pl) 2001-10-17 2002-10-16 Kompozycje farmaceutyczne zawierające kwas mykofenolowy lub sól mykofenolanową
AU2002338897A AU2002338897B2 (en) 2001-10-17 2002-10-16 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt
AT02777314T ATE374023T1 (de) 2001-10-17 2002-10-16 Pharmazeutische zusammensetzungen enthaltend mycophenolsäure oder ein mycophenolat salz
IL16096802A IL160968A0 (en) 2001-10-17 2002-10-16 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt
DE60222687.2T DE60222687T3 (de) 2001-10-17 2002-10-16 Pharmazeutische zusammensetzungen enthaltend mycophenolsäure oder ein mycophenolat salz
CA002460574A CA2460574A1 (en) 2001-10-17 2002-10-16 Enteric coated tablets comprising mycophenolic acid or mycophenolate salt
PCT/EP2002/011589 WO2003032978A1 (en) 2001-10-17 2002-10-16 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt
JP2003535782A JP2005508959A (ja) 2001-10-17 2002-10-16 ミコフェノール酸またはミコフェノール酸塩を含む医薬組成物
BRPI0213355-5A BR0213355A (pt) 2001-10-17 2002-10-16 composições farmacêuticas
PT02777314T PT1438040E (pt) 2001-10-17 2002-10-16 Composições farmacológicas incluindo ácido micofenólico ou sal micofenolato
EP02777314.2A EP1438040B2 (en) 2001-10-17 2002-10-16 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt
KR1020047005588A KR100671367B1 (ko) 2001-10-17 2002-10-16 미코페놀산 또는 미코페놀레이트 염을 포함하는 제약조성물
MXPA04003636A MXPA04003636A (es) 2001-10-17 2002-10-16 Composiciones farmaceuticas que comprenden acido micofenolico o sal de micofenolato.
SI200230646T SI1438040T2 (sl) 2001-10-17 2002-10-16 Farmacevtski sestavki, ki vključujejo mikofenolno kislino ali sol mikofenolat
DK02777314.2T DK1438040T4 (da) 2001-10-17 2002-10-16 Farmaceutiske sammensætninger indeholdende mycophenolsyre eller et mycophenolsalt
NZ532280A NZ532280A (en) 2001-10-17 2002-10-16 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt
PL367738A PL234541B1 (pl) 2001-10-17 2002-10-16 Sposób wytwarzania tabletki dojelitowej zawierającej kwas mykofenolowy lub sól mykofenolanową
ES02777314T ES2292819T5 (es) 2001-10-17 2002-10-16 Composiciones farmacéuticas que comprenden ácido micofenólico o sal de micofenolato
US10/492,289 US20050013859A1 (en) 2001-10-17 2002-10-16 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt
EC2002004341A ECSP024341A (es) 2001-10-17 2002-11-19 Composiciones farmaceuticas
EC2002004342A ECSP024342A (es) 2001-10-17 2002-11-19 Nuevos derivados d e fenilpropargileter
ZA200401977A ZA200401977B (en) 2001-10-17 2004-03-11 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt
IL160968A IL160968A (en) 2001-10-17 2004-03-18 Pharmaceutical preparations containing mycophenolic acid or mycophenolate salt
NO20041785A NO341804B1 (no) 2001-10-17 2004-05-03 Fremgangsmåte for fremstilling av en farmasøytisk sammensetning som innbefatter mykofenolsyre eller mykofenolatsalt.
RU2007130786/15A RU2381026C2 (ru) 2001-10-17 2007-08-13 Фармацевтические композиции, содержащие микофенольную кислоту или ее соль (микофенолят)
CY20071101618T CY1107841T1 (el) 2001-10-17 2007-12-19 Φαρμακευτικα σκευασματα τα οποια περιλαμβανουν μυκοφαινολικο οξυ ή μυκοφαινολικο αλας
JP2009012781A JP2009137996A (ja) 2001-10-17 2009-01-23 ミコフェノール酸またはミコフェノール酸塩を含む医薬組成物
US12/772,608 US20100210717A1 (en) 2001-10-17 2010-05-03 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt
ARP120101574A AR085778A2 (es) 2001-10-17 2012-05-04 Forma de dosis solida enterica revestida, que comprende acido micofenolico o sal micofenolato
US13/482,003 US20120237601A1 (en) 2001-10-17 2012-05-29 Pharmaceutical Compositions Comprising Mycophenolic Acid or Mycophenolate Salt

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0124953.1A GB0124953D0 (en) 2001-10-17 2001-10-17 Organic Compounds

Publications (1)

Publication Number Publication Date
GB0124953D0 true GB0124953D0 (en) 2001-12-05

Family

ID=9924043

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0124953.1A Ceased GB0124953D0 (en) 2001-10-17 2001-10-17 Organic Compounds

Country Status (31)

Country Link
US (3) US20050013859A1 (enExample)
EP (1) EP1438040B2 (enExample)
JP (2) JP2005508959A (enExample)
KR (1) KR100671367B1 (enExample)
CN (1) CN1310640C (enExample)
AR (2) AR036813A1 (enExample)
AT (1) ATE374023T1 (enExample)
AU (1) AU2002338897B2 (enExample)
BR (1) BR0213355A (enExample)
CA (1) CA2460574A1 (enExample)
CO (1) CO5390076A1 (enExample)
CY (1) CY1107841T1 (enExample)
DE (1) DE60222687T3 (enExample)
DK (1) DK1438040T4 (enExample)
EC (2) ECSP024342A (enExample)
ES (1) ES2292819T5 (enExample)
GB (1) GB0124953D0 (enExample)
HU (1) HU231114B1 (enExample)
IL (2) IL160968A0 (enExample)
MX (1) MXPA04003636A (enExample)
MY (1) MY139206A (enExample)
NO (1) NO341804B1 (enExample)
NZ (1) NZ532280A (enExample)
PE (1) PE20030476A1 (enExample)
PL (2) PL234541B1 (enExample)
PT (1) PT1438040E (enExample)
RU (2) RU2338528C2 (enExample)
SI (1) SI1438040T2 (enExample)
TW (1) TWI333861B (enExample)
WO (1) WO2003032978A1 (enExample)
ZA (1) ZA200401977B (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124953D0 (en) 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
AR045957A1 (es) * 2003-10-03 2005-11-16 Novartis Ag Composicion farmaceutica y combinacion
CN101052631A (zh) * 2004-07-20 2007-10-10 特瓦药厂私人有限公司 结晶霉酚酸钠
GB0419355D0 (en) * 2004-08-31 2004-09-29 Novartis Ag Organic compounds
WO2006086498A2 (en) * 2005-02-08 2006-08-17 Aspreva Pharmaceuticals Sa Treatment of vascular, autoimmune and inflammatory diseases using low dosages of impdh inhibitors
WO2006086500A2 (en) * 2005-02-08 2006-08-17 Aspreva Pharmaceuticals Sa Compositions and methods for treating vascular, autoimmune and inflammatory diseases
EP1940388A2 (en) * 2005-09-30 2008-07-09 Novartis AG Dpp iv inhibtor for use in the treatment of autoimmune diseases and graft rejection
EP1965760B1 (de) 2005-12-21 2013-02-27 Basf Se Feinteiliges quervernetztes polyvinylpyrrolidon als tablettensprengmittel
CA2640283A1 (en) * 2006-02-13 2007-08-23 Novartis Ag High dosage of mycophenolic acid (mpa)
WO2008148742A2 (de) 2007-06-06 2008-12-11 Basf Se Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
US8568780B2 (en) 2007-06-06 2013-10-29 Basf Se Pharmaceutical formulation for the production of rapidly disintegrating tablets
MX2010001711A (es) * 2007-08-13 2010-03-11 Panacea Biotec Ltd Composiciones de liberacion extendida que comprenden micofenolato sodico y procedimientos de las mismas.
AU2009220779A1 (en) * 2008-03-05 2009-09-11 Panacea Biotec Limited Modified release pharmaceutical compositions comprising mycophenolate and processes thereof
US20100010082A1 (en) * 2008-07-09 2010-01-14 Aspreva International Ltd. Formulations for treating eye disorders
US20110086102A1 (en) * 2009-10-13 2011-04-14 Teva Pharmaceutical Industries Ltd. Delayed release compositions
WO2011046546A1 (en) * 2009-10-13 2011-04-21 Teva Pharmaceutical Industries Ltd. Delayed release compositions
WO2011051967A2 (en) * 2009-10-23 2011-05-05 Alkem Laboratories Ltd Pharmaceutical compositions comprising mycophenolate and processes for preparing thereof
GB201100786D0 (en) 2011-01-18 2011-03-02 Ems Sa Pharmaceutical compositions of immunosuppressants
CN102793658A (zh) * 2012-08-23 2012-11-28 无锡福祈制药有限公司 一种含有麦考酚酸或麦考酚酸盐的骨架型制剂及其包衣片
CN103845323B (zh) * 2012-11-30 2018-02-02 重庆华邦制药有限公司 麦考酚酸及其盐肠溶制剂和制备方法
WO2014167442A1 (en) 2013-03-26 2014-10-16 Wockhardt Limited Pharmaceutical compositions comprising mycophenolic acid or salts thereof
CN106727403A (zh) * 2017-01-03 2017-05-31 无锡福祈制药有限公司 一种麦考酚钠肠溶片及其制备方法
JP7385474B2 (ja) * 2017-03-13 2023-11-22 オカヴァ ファーマシューティカルズ， インコーポレイテッド 非ヒト哺乳動物にミコフェノール酸活性剤を送達すための方法および組成物
CA3102412A1 (en) 2018-06-06 2019-12-12 Metavant Sciences Gmbh Methods of treating subjects having diabetes with chronic kidney disease
WO2019238647A1 (en) * 2018-06-14 2019-12-19 Poxel Film-coated tablet comprising a triazine derivative for use in the treatment of diabetes
RU2723255C2 (ru) * 2018-11-14 2020-06-09 Общество с ограниченной ответственностью "Изварино Фарма" Экструдат с микофенолятом натрия для получения пероральной твердой лекарственной формы
EP4438037A1 (en) * 2021-01-28 2024-10-02 Priothera SAS Methods of treatment with s1p receptor modulators
EP4346790A4 (en) * 2021-05-26 2025-04-16 The Texas A&M University System Biodegradable mucoadhesive pharmaceutical formulations and methods thereof
CN117442580B (zh) * 2023-12-21 2024-04-05 泊诺(天津)创新医药研究有限公司 一种高生物利用度麦考酚钠肠溶片及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1157100A (en) † 1966-09-27 1969-07-02 Ici Ltd Pharmaceutical Compositions
GB1157099A (en) * 1966-09-27 1969-07-02 Ici Ltd Fermentation Process
GB1203328A (en) * 1968-06-04 1970-08-26 Ici Ltd Pharmaceutical compositions
US3705946A (en) * 1971-05-25 1972-12-12 Lilly Co Eli Method of treating hyperuricemia
US3880995A (en) * 1973-05-14 1975-04-29 Lilly Co Eli Treatment of arthritis with mycophenolic acid and derivatives
JPS56127093A (en) * 1980-03-10 1981-10-05 Ajinomoto Co Inc Preparation of mycophenolic acid
US4959387A (en) * 1986-01-23 1990-09-25 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4725622A (en) * 1986-01-23 1988-02-16 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4753935A (en) * 1987-01-30 1988-06-28 Syntex (U.S.A.) Inc. Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
US4748173A (en) * 1987-01-30 1988-05-31 Syntex (U.S.A.) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof and pharmaceutical compositions
US5177072A (en) * 1987-01-30 1993-01-05 Syntex (U.S.A.) Inc. Treatment of autoimmune inflammatory, and psoriatic diseases with heterocyclic aminoalkyl esters of mycophenolic acid and derivatives
AU3178293A (en) * 1992-11-24 1994-06-22 Syntex (U.S.A.) Inc. Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
WO1994012184A1 (en) * 1992-11-24 1994-06-09 Syntex (U.S.A.) Inc. Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
US5843479A (en) * 1993-02-26 1998-12-01 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5656290A (en) * 1993-02-26 1997-08-12 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
DK0686034T3 (da) * 1993-02-26 2001-08-27 Procter & Gamble Bisacodyl-doseringsform
US5651983A (en) * 1993-02-26 1997-07-29 The Procter & Gamble Company Bisacodyl dosage form for colonic delivery
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations
ES2248793T3 (es) * 1993-10-01 2006-03-16 Roche Palo Alto Llc Suspensiones orales de alta dosis de mofetil micofenolato.
WO1995011024A1 (en) * 1993-10-19 1995-04-27 The Procter & Gamble Company Picosulphate dosage form
US5514663A (en) * 1993-10-19 1996-05-07 The Procter & Gamble Company Senna dosage form
US5482718A (en) * 1994-03-23 1996-01-09 Hoffmann-La Roche Inc. Colon-targeted delivery system
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
ID18663A (id) * 1996-04-12 1998-04-30 Novartis Ag Komposisi farmasi berlapis enterik
WO2000067773A2 (en) * 1999-05-10 2000-11-16 Novartis Ag Combinations of immunosupressive agents for the treatment or prevention of graft rejections
HUP9903226A2 (en) * 1999-09-23 2002-08-28 Gyogyszerki Process for producing mycophenolic acid and derivatives thereof
EP1259631B1 (en) * 2000-02-29 2005-10-12 Biocon Limited Manufacture and purification of mycophenolic acid
GB0124953D0 (en) 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
GB0301259D0 (en) 2003-01-20 2003-02-19 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
US20050013859A1 (en) 2005-01-20
DE60222687T3 (de) 2020-03-05
TWI333861B (en) 2010-12-01
US20120237601A1 (en) 2012-09-20
ECSP024341A (es) 2003-12-01
ZA200401977B (en) 2006-05-31
MXPA04003636A (es) 2004-07-27
ATE374023T1 (de) 2007-10-15
BR0213355A (pt) 2006-05-23
KR20050037409A (ko) 2005-04-21
NO341804B1 (no) 2018-01-22
CN1564684A (zh) 2005-01-12
IL160968A0 (en) 2004-08-31
AU2002338897B2 (en) 2006-10-19
SI1438040T2 (sl) 2020-02-28
EP1438040B1 (en) 2007-09-26
PT1438040E (pt) 2008-01-02
MY139206A (en) 2009-08-28
PL415001A1 (pl) 2016-02-29
RU2007130786A (ru) 2009-02-20
PL367738A1 (en) 2005-03-07
DK1438040T4 (da) 2020-01-27
PL234541B1 (pl) 2020-03-31
SI1438040T1 (sl) 2008-04-30
JP2009137996A (ja) 2009-06-25
EP1438040B2 (en) 2019-10-16
NO20041785L (no) 2004-05-03
DE60222687T2 (de) 2008-07-17
US20100210717A1 (en) 2010-08-19
ES2292819T3 (es) 2008-03-16
CY1107841T1 (el) 2013-06-19
HU231114B1 (hu) 2020-09-28
EP1438040A1 (en) 2004-07-21
CO5390076A1 (es) 2004-04-30
JP2005508959A (ja) 2005-04-07
HUP0600451A2 (en) 2006-09-28
IL160968A (en) 2016-04-21
DE60222687D1 (de) 2007-11-08
DK1438040T3 (da) 2008-02-04
PE20030476A1 (es) 2003-07-30
RU2381026C2 (ru) 2010-02-10
AR085778A2 (es) 2013-10-30
HK1067861A1 (en) 2005-04-22
ES2292819T5 (es) 2020-05-29
CN1310640C (zh) 2007-04-18
CA2460574A1 (en) 2003-04-24
NZ532280A (en) 2007-05-31
AR036813A1 (es) 2004-10-06
RU2338528C2 (ru) 2008-11-20
WO2003032978A1 (en) 2003-04-24
ECSP024342A (es) 2003-03-10
RU2004115332A (ru) 2005-04-20
KR100671367B1 (ko) 2007-01-19

Similar Documents

Publication Publication Date Title
GB0108876D0 (en) Organic Compounds
GB0124953D0 (en) Organic Compounds
GB0103389D0 (en) Organic compounds
GB0108606D0 (en) Organic compounds
GB0108337D0 (en) Organic compounds
GB0103303D0 (en) Organic compounds
GB0108087D0 (en) Organic compounds
GB0107368D0 (en) Organic compounds
GB0103258D0 (en) Organic compounds
GB0101598D0 (en) Organic compounds
GB0113307D0 (en) Organic compounds
GB0102841D0 (en) Organic compounds
GB0107365D0 (en) Organic compounds
GB0108101D0 (en) Organic compounds
GB0102089D0 (en) Organic Compounds
GB0102379D0 (en) Organic compounds
GB0102839D0 (en) Organic compounds
GB0107507D0 (en) Organic compounds
GB0109727D0 (en) Organic compounds
GB0102269D0 (en) Organic compounds
GB0102093D0 (en) Organic Compounds
GB0108352D0 (en) Organic compounds
GB0108346D0 (en) Organic compounds
GB0102092D0 (en) Organic compounds
GB0107508D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)